Not applicableStudy completedNCT01549327What this trial is testingThe Effect of a Virtual Navigator on Colorectal Cancer Patient EmpowermentWho this might be right forColorectal Cancer McGill University 129
Testing effectiveness (Phase 2)Ended earlyNCT00843310What this trial is testingCombination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple MyelomaWho this might be right forMultiple Myeloma NYU Langone Health 8
Testing effectiveness (Phase 2)WithdrawnNCT00005083What this trial is testingFunctional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT07374029What this trial is testingAdoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AMLWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia, in Relapse David Avigan 30
Testing effectiveness (Phase 2)Study completedNCT01847001What this trial is testingStudy of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyWho this might be right forLocally Advanced Malignant NeoplasmBreast Cancer Columbia University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05573802What this trial is testingInvestigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple MyelomaWho this might be right forMultiple MyelomaNeoplasmsNeoplasm, Plasma Cell+5 more Hellenic Society of Hematology 36
Testing effectiveness (Phase 2)Study completedNCT00930605What this trial is testingThe Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)Who this might be right forPeripheral T-cell Lymphoma King Chulalongkorn Memorial Hospital 16
Testing effectiveness (Phase 2)Looking for participantsNCT05245656What this trial is testingA Study Comparing Rituximab/Bendamustin(RB) Alternating With Rituximab/Bendamustin/Cytarabin(RBAC) With RB Therapy in Elderly Patients With Mentle Cell LymphomaWho this might be right forMantle Cell Lymphoma Kim, Seok Jin 90
Not applicableActive Not RecruitingNCT06125795What this trial is testingAssess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in SpainWho this might be right forChronic Lymphocytic Leukemia AbbVie 146
Not applicableUnknownNCT05218603What this trial is testingEvaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCTWho this might be right forMultiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT) PETHEMA Foundation 100
Testing effectiveness (Phase 2)UnknownNCT02437812What this trial is testingStudy of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian CarcinomaWho this might be right forEpithelial Ovarian Carcinoma Gynecologic Oncology Associates 30
Testing effectiveness (Phase 2)Looking for participantsNCT07415681What this trial is testingGCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic PrimariesWho this might be right forGynaecologic CancerCervical CancerRadiation Therapy University of Maryland, Baltimore 116
Not applicableStudy completedNCT02918695What this trial is testingComparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma PatientsWho this might be right forMultiple MyelomaHematologic Diseases Universitaire Ziekenhuizen KU Leuven 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07732712What this trial is testingIsa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma CellsWho this might be right forMultiple Myeloma The Affiliated People's Hospital of Ningbo University 15
Post-approval studies (Phase 4)Study completedNCT02546674What this trial is testingStudy Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.Who this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 171
Very early researchActive Not RecruitingNCT01189643What this trial is testingIrinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell TumorWho this might be right forSarcomaDesmoplastic Small Round Cell Tumor (DSRCT) Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)Looking for participantsNCT07478991What this trial is testingAzacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)Who this might be right forAcute Myeloid Leukemia, Adult PETHEMA Foundation 376
Not applicableUnknownNCT00397124What this trial is testingThe Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer PatientsWho this might be right forLung Cancer Rambam Health Care Campus 40
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06427213What this trial is testingThis is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell LymphomaWho this might be right forLymphoma, Mantle-CellLymphoma, Non-Hodgkin Henan Cancer Hospital 41